# Correction: New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies

## TL;DR

This paper corrects a previous study on new compounds that may help in breast cancer treatment by affecting cell death and enzymes.

## Contribution

The paper provides a correction to prior research on multifunctional hybrids for breast cancer therapy.

## Key findings

- The original study focused on the synthesis and testing of new compounds.
- These compounds were shown to influence apoptosis and topoisomerase II.
- In vitro and in silico methods were used to evaluate their potential.

## Abstract

Correction for ‘New multifunctional hybrids as modulators of apoptosis markers and topoisomerase II in breast cancer therapy: synthesis, characterization, and in vitro and in silico studies’ by Heba W. Alhamdi et al., RSC Adv., 2024, 14, 28555–28568, https://doi.org/10.1039/D4RA04219K.